Peripheral Blood and Skin Sample Collection for Cutaneous Lymphoma Research
The purpose of this study is to provide a central mechanism for monitoring access to
peripheral blood and skin specimens obtained from CTCL patients to monitor:
- immunologic assays/flow cytometry
- tumor progression/regression
- genomic studies
- proteomic studies
- others germane to the advancement of CTCL treatment
Time Perspective: Prospective
Proteonomics of Cutaneous T-cell lymphoma
Proteonomic variables will be measured in blood and tissue of consented CTCL patients.
Larisa J. Geskin, M.D.
University of Pittsburgh
United States: Food and Drug Administration
|University of Pittsburgh Medical Center||Pittsburgh, Pennsylvania 15213|